Table 2.
Sexually Transmitted Disease Follow-up Event Rates and Intent-to-Treat Population Total Follow-up for the Cohort (1137.4 Person-years in 1365 Subjects)
| Randomization Arm | Gonorrhea |
Chlamydia |
Gonorrhea or Chlamydia |
|||
|---|---|---|---|---|---|---|
| BV Treatment (n = 683) | No BV Treatment (n = 682) | BV Treatment (n = 683) | No BV Treatment (n = 682) | BV Treatment (n = 683) | No BV Treatment (n = 682) | |
| Total follow-up, person-years | 580.0 | 557.4 | 580.0 | 557.4 | 580.0 | 557.4 |
| Total visits with any STD, No. | 26 | 19 | 80 | 88 | 106 | 107 |
| Rate per 100 person-years (95% CI) | 4.5 (3.1–6.6) | 3.4 (2.2–5.3) | 13.8 (11.1–17.2) | 15.8 (12.8–19.5) | 18.3 (15.1–22.1) | 19.2 (15.9–23.2) |
| Rate difference (95% CI) | 1.1 (−4.0 to 6.1) (P = .46) | −2.0 (−11.8 to 7.8) (P = .47) | −0.9 (−12.0 to 10.1) (P = .75) | |||
Abbreviations: BV, bacterial vaginosis; CI, confidence interval; STD, sexually transmitted disease.